Back to search

United Kingdom· GB-APID-21993811000001107

Lecado 200mg/50mg modified-release tablets

A medicinal product containing co-careldopa, registered in United Kingdom by Sandoz Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLecado 200mg/50mg modified-release ta…ATC—REGISTER NO.GB-APID-2199381100000…PACKS LISTED3CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Co-careldopa
Manufacturer
Sandoz Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    5050650044027
  • gtin
    05050650044027
  • gtin
    07613421057237

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a8c27b52-2ebf-4ad7-9391-5385e5876377
GET /v1/drugs/a8c27b52-2ebf-4ad7-9391-5385e5876377?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "21993811000001107",
  "desc": "Lecado 200mg/50mg modified-release tablets (Sandoz Ltd)",
  "form": "Modified-release tablet",
  "vpid": "39109211000001100",
  "source": "dmd",
  "vtm_id": "775053005",
  "strength": "50 mg",
  "substance": "Co-careldopa",
  "ingredient": "Carbidopa monohydrate",
  "supplier_code": "2074301000001102"
}

See everything about co-careldopa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.